Cargando…
Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies
Roux-en-Y gastric bypass (RYGB) improves, and can sometimes resolve, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) but data based on histological assessment for the efficacy of sleeve gastrectomy (SG) in resolving NAFLD are sparse. Consequently, we aimed to compa...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432029/ https://www.ncbi.nlm.nih.gov/pubmed/34501231 http://dx.doi.org/10.3390/jcm10173783 |
_version_ | 1783751069538451456 |
---|---|
author | Pedersen, Julie Steen Rygg, Marte Opseth Serizawa, Reza Rafiolsadat Kristiansen, Viggo Bjerregaard Albrechtsen, Nicolai J. Wewer Gluud, Lise Lotte Madsbad, Sten Bendtsen, Flemming |
author_facet | Pedersen, Julie Steen Rygg, Marte Opseth Serizawa, Reza Rafiolsadat Kristiansen, Viggo Bjerregaard Albrechtsen, Nicolai J. Wewer Gluud, Lise Lotte Madsbad, Sten Bendtsen, Flemming |
author_sort | Pedersen, Julie Steen |
collection | PubMed |
description | Roux-en-Y gastric bypass (RYGB) improves, and can sometimes resolve, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) but data based on histological assessment for the efficacy of sleeve gastrectomy (SG) in resolving NAFLD are sparse. Consequently, we aimed to compare the efficacy of RYGB vs. SG on NAFLD 12 months after surgery. In a prospective cohort study, 40 patients with obesity underwent bariatric surgery (16 RYGB and 24 SG). During surgery, a liver biopsy was taken and repeated 12 months later. NAFLD severity was evaluated using the NAFLD Activity Score (NAS) and Kleiner Fibrosis score. RYGB and SG patients were comparable at baseline. Mean (standard deviation, SD) NAS was 3.3 (0.9) in RYGB and 3.1 (1.4) in SG (p = 0.560) with similar degrees of steatosis, inflammation, and ballooning. Two RYGB patients, and six SG patients, had NASH (p = 0.439). Twelve months after surgery, NAS was significantly and comparably (p = 0.241) reduced in both RYGB (−3.00 (95% CI −3.79–−2.21), p < 0.001) and SG (−2.25 (95% CI −2.92–−1.59), p < 0.001) patients. RYGB patients had significantly more reduced (p = 0.007) liver steatosis (−0.91 (95% CI −1.47–−1.2) than SG patients (−0.33 (95% CI −0.54–−0.13) and greater improvement in the plasma lipid profile. Fibrosis declined non-significantly. NASH was resolved in seven of eight patients without a worsening of their fibrosis. RYGB and SG have similar beneficial effects on NAS and NASH without the worsening of fibrosis. RYGB is associated with a more pronounced reduction in liver steatosis. |
format | Online Article Text |
id | pubmed-8432029 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84320292021-09-11 Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies Pedersen, Julie Steen Rygg, Marte Opseth Serizawa, Reza Rafiolsadat Kristiansen, Viggo Bjerregaard Albrechtsen, Nicolai J. Wewer Gluud, Lise Lotte Madsbad, Sten Bendtsen, Flemming J Clin Med Article Roux-en-Y gastric bypass (RYGB) improves, and can sometimes resolve, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) but data based on histological assessment for the efficacy of sleeve gastrectomy (SG) in resolving NAFLD are sparse. Consequently, we aimed to compare the efficacy of RYGB vs. SG on NAFLD 12 months after surgery. In a prospective cohort study, 40 patients with obesity underwent bariatric surgery (16 RYGB and 24 SG). During surgery, a liver biopsy was taken and repeated 12 months later. NAFLD severity was evaluated using the NAFLD Activity Score (NAS) and Kleiner Fibrosis score. RYGB and SG patients were comparable at baseline. Mean (standard deviation, SD) NAS was 3.3 (0.9) in RYGB and 3.1 (1.4) in SG (p = 0.560) with similar degrees of steatosis, inflammation, and ballooning. Two RYGB patients, and six SG patients, had NASH (p = 0.439). Twelve months after surgery, NAS was significantly and comparably (p = 0.241) reduced in both RYGB (−3.00 (95% CI −3.79–−2.21), p < 0.001) and SG (−2.25 (95% CI −2.92–−1.59), p < 0.001) patients. RYGB patients had significantly more reduced (p = 0.007) liver steatosis (−0.91 (95% CI −1.47–−1.2) than SG patients (−0.33 (95% CI −0.54–−0.13) and greater improvement in the plasma lipid profile. Fibrosis declined non-significantly. NASH was resolved in seven of eight patients without a worsening of their fibrosis. RYGB and SG have similar beneficial effects on NAS and NASH without the worsening of fibrosis. RYGB is associated with a more pronounced reduction in liver steatosis. MDPI 2021-08-24 /pmc/articles/PMC8432029/ /pubmed/34501231 http://dx.doi.org/10.3390/jcm10173783 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pedersen, Julie Steen Rygg, Marte Opseth Serizawa, Reza Rafiolsadat Kristiansen, Viggo Bjerregaard Albrechtsen, Nicolai J. Wewer Gluud, Lise Lotte Madsbad, Sten Bendtsen, Flemming Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies |
title | Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies |
title_full | Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies |
title_fullStr | Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies |
title_full_unstemmed | Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies |
title_short | Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies |
title_sort | effects of roux-en-y gastric bypass and sleeve gastrectomy on non-alcoholic fatty liver disease: a 12-month follow-up study with paired liver biopsies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432029/ https://www.ncbi.nlm.nih.gov/pubmed/34501231 http://dx.doi.org/10.3390/jcm10173783 |
work_keys_str_mv | AT pedersenjuliesteen effectsofrouxenygastricbypassandsleevegastrectomyonnonalcoholicfattyliverdiseasea12monthfollowupstudywithpairedliverbiopsies AT ryggmarteopseth effectsofrouxenygastricbypassandsleevegastrectomyonnonalcoholicfattyliverdiseasea12monthfollowupstudywithpairedliverbiopsies AT serizawarezarafiolsadat effectsofrouxenygastricbypassandsleevegastrectomyonnonalcoholicfattyliverdiseasea12monthfollowupstudywithpairedliverbiopsies AT kristiansenviggobjerregaard effectsofrouxenygastricbypassandsleevegastrectomyonnonalcoholicfattyliverdiseasea12monthfollowupstudywithpairedliverbiopsies AT albrechtsennicolaijwewer effectsofrouxenygastricbypassandsleevegastrectomyonnonalcoholicfattyliverdiseasea12monthfollowupstudywithpairedliverbiopsies AT gluudliselotte effectsofrouxenygastricbypassandsleevegastrectomyonnonalcoholicfattyliverdiseasea12monthfollowupstudywithpairedliverbiopsies AT madsbadsten effectsofrouxenygastricbypassandsleevegastrectomyonnonalcoholicfattyliverdiseasea12monthfollowupstudywithpairedliverbiopsies AT bendtsenflemming effectsofrouxenygastricbypassandsleevegastrectomyonnonalcoholicfattyliverdiseasea12monthfollowupstudywithpairedliverbiopsies |